tradingkey.logo
tradingkey.logo
Search

Theratechnologies Receives FDA Approval Of Prior Approval Supplement (Pas) For Egrifta Sv® Sbla

ReutersApr 8, 2025 11:02 AM
facebooktwitterlinkedin

- Theratechnologies Inc TH.TO:

  • THERATECHNOLOGIES RECEIVES FDA APPROVAL OF PRIOR APPROVAL SUPPLEMENT (PAS) FOR EGRIFTA SV® SBLA

  • THERATECHNOLOGIES: FDA ACTION ALLOWS FOR UNRESTRICTED DISTRIBUTION OF EGRIFTA SV, REMOVING UNCERTAINTY ABOUT ALL MANUFACTURED BATCHES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI